The death of a 16-year-old boy taking a gene therapy this month dealt a fresh blow to the Duchenne muscular dystrophy ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Its maker, Sarepta Therapeutics, hasn’t ruled out the possibility that the treatment, which uses an adeno-associated virus vector ... to adenovirus vectors, the first type used for gene therapy ...

The facility is equipped for advanced viral vector production, designed to produce high-titer viral vectors such as AAV, Lentivirus, and Adenovirus, which are essential for cell and gene therapy ...

Ferring Pharma’s Adstiladrin is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy. Its safety and efficacy was evaluated in a multi-centre clinical study of ...

Bharat Biotech International Limited (BBIL), has launched India’s only vertically integrated, purpose-designed cell & gene therapy (CGT) infrastructure & viral vector production ... Lentivirus, ...

Vaccine maker Bharat Biotech International Ltd (BBIL) has set up India’s only vertically integrated, purpose-designed Cell & Gene Therapy (C&GT) Infrastructure & Viral Vector Production facility ...

Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...